TP
Tarun Pratap Singh
About Tarun Pratap Singh
Data last updated:
Tarun Pratap Singh has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Skama Biotech Private Limited and Shinata Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The largest current company by reported revenue is Skama Biotech Private Limited at ₹2.37 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 May 2016 | 2016 | ₹2.37 Cr (FY 2025) | Active | |
| Director | 30 Sep 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tarun Pratap Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tarun Pratap Singh
Tarun Pratap Singh has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Skama Biotech Private Limited and Shinata Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The largest current company by reported revenue is Skama Biotech Private Limited at ₹2.37 Cr (FY 2025).
Tarun Pratap Singh is associated with 2 companies as Director, including Skama Biotech Private Limited (₹2.37 Cr), Shinata Pharma Private Limited.
Tarun Pratap Singh has expertise in Technology, General Business.
Tarun Pratap Singh has 10 years in corporate governance.
By reported revenue, the largest current company of Tarun Pratap Singh is Skama Biotech Private Limited, with revenue of ₹2.37 Cr (FY 2025).
Tarun Pratap Singh currently holds positions at 2 companies: Skama Biotech Private Limited (₹2.37 Cr), Shinata Pharma Private Limited.